Results

Total Results: 1,511 records

Showing results for "drugs".

1. Prescribing Patterns of Cost-Effective Drugs (pdf file)
   digital.ahrq.gov/sites/default/files/docs/page/prescribing-patterns-of-cost-effective-drugs-quick-reference-guide.pdf
   April 01, 2009 - Prescribing Patterns of Cost-Effective Drugs Prescribing Patterns of Cost­Effective Drugs Evaluating … You may want to only examine a particular category of drugs. … to adjust for drug categories to account for possible confounding, since different categories of drugs … This includes taking into account classes of drugs where e­prescribing may not be an option, for example … AHRQ Publication No: 09­0047 April 2009 Prescribing Patterns ofCost-Effective Drugs Methodology

2. Drugs that interact with colchicine via inhibition of cytochrome p450 3A4 and p-glycoprotein: A signal detection analysis using a database of spontaneously reported adverse events (FAERS). | Digital Healthcare Research
   digital.ahrq.gov/ahrq-funded-projects/meaningful-drug-interaction-alerts/citation/drugs
   January 01, 2023 - Drugs that interact with colchicine via inhibition of cytochrome p450 3A4 and p-glycoprotein: A signal … Drugs that interact with colchicine via inhibition of cytochrome p450 3A4 and p-glycoprotein: A signal

3. NDC | Digital Healthcare Research
   digital.ahrq.gov/ndc
   January 01, 2022 - are ambiguous; many NDCs can exist for a single product, leading to inaccuracies in the dispensing of drugs … Library of Medicine (NLM) has been working on RxNorm , which provides "standard names for clinical drugs … Background The National Drug Codes (NDCs) are standards for reporting drugs and biological products … The Drug Listing Act of 1972 requires that all drug-producing establishments report to the FDA all drugs … Only selected non-prescription drugs are included in the NDC database.

4. Use of hepatotoxic drugs in chronic liver disease. | Digital Healthcare Research
   digital.ahrq.gov/ahrq-funded-projects/health-information-technology-center-education-and-research-therapeutics-4
   January 01, 2022 - Use of hepatotoxic drugs in chronic liver disease. … Use of hepatotoxic drugs in chronic liver disease.

5. Querying the National Drug File Reference Terminology (NDFRT) to assign drugs to decision support categories. | Digital Healthcare Research
   digital.ahrq.gov/ahrq-funded-projects/value-new-drug-labeling-knowledge-e-prescribing/citation/querying-national-drug
   January 01, 2022 - Querying the National Drug File Reference Terminology (NDFRT) to assign drugs to decision support categories … Querying the National Drug File Reference Terminology (NDFRT) to assign drugs to decision support categories

6. Prior authorization for biologic disease-modifying antirheumatic drugs: a description of US Medicaid programs. | Digital Healthcare Research
   digital.ahrq.gov/ahrq-funded-projects/impact-office-based-e-prescribing-prescribing-processes-and-outcomes/citation-1
   January 01, 2022 - Prior authorization for biologic disease-modifying antirheumatic drugs: a description of US Medicaid … Prior authorization for biologic disease-modifying antirheumatic drugs: a description of US Medicaid

7. Preventability of adverse drug events involving multiple drugs using publicly available clinical decision support tools. | Digital Healthcare Research
   digital.ahrq.gov/ahrq-funded-projects/health-information-technology-and-improving-medication-use/citation-2
   January 01, 2022 - Preventability of adverse drug events involving multiple drugs using publicly available clinical decision … Preventability of adverse drug events involving multiple drugs using publicly available clinical decision

8. Risk of bleeding with exposure to warfarin and nonsteroidal anti-inflammatory drugs: a systematic review and meta-analysis. | Digital Healthcare Research
   digital.ahrq.gov/ahrq-funded-projects/individualized-drug-interaction-alerts/citation/risk
   January 01, 2022 - Risk of bleeding with exposure to warfarin and nonsteroidal anti-inflammatory drugs: a systematic review … Risk of bleeding with exposure to warfarin and nonsteroidal anti-inflammatory drugs: a systematic review

9. A shared decision-making tool for drug interactions between warfarin and nonsteroidal anti-inflammatory drugs: Design and usability study. | Digital Healthcare Research
   digital.ahrq.gov/ahrq-funded-projects/enabling-shared-decision-making-reduce-harm-drug-interactions-end-end/citation/shared
   January 01, 2022 - shared decision-making tool for drug interactions between warfarin and nonsteroidal anti-inflammatory drugs … shared decision-making tool for drug interactions between warfarin and nonsteroidal anti-inflammatory drugs

10. Tools for Optimizing Medication Safety (TOP-MEDS) - 2011 | Digital Healthcare Research
    digital.ahrq.gov/ahrq-funded-projects/tools-optimizing-medication-safety-top-meds/annual-summary/2011
    January 01, 2011 - initiative to conduct research and provide education to advance the optimal use of therapeutics such as drugs … High-risk commonly used drugs such as opioid analgesics are frequently selected and dosed improperly. … Drug name confusion causes patients to receive the wrong drugs. … Consumers use drugs unsafely because drug information is limited and/or confusing.

11. Assessment of Pediatric Look-Alike, Sound-Alike Substitution Errors - 2012 | Digital Healthcare Research
    digital.ahrq.gov/ahrq-funded-projects/assessment-pediatric-look-alike-sound-alike-substitution-errors/annual-summary/2012
    January 01, 2012 - The Delphi process identified the drugs that the participants thought to be of high potential patient … team used a Food and Drug Administration (FDA) file that cross-referenced the brand name and generic drugs … drug pairs included in the final round of the Delphi process did not have a person who received both drugs … errors for these pairs is feasible in the pharmacy setting, so any patient who receives both of these drugs … For 505 pairs (83 percent), the cumulative total of subjects who received both drugs in a pair was 3,610

12. Implementation of rules based computerised bedside prescribing and administration: intervention study | AHRQ Digital Healthcare Research: Informing Improvement in Care Quality, Safety, and Efficiency
    digital.ahrq.gov/health-it-tools-and-resources/health-it-costs-and-benefits-database/implementation-rules-based
    March 18, 2021 - prescribing system with the aim of improving the safety of prescriptions and the administration of drugs … Intervention:  A rules based system for prescribing and recording the administration of drugs which was … computerized prescribing system with the aim of improving the safety of prescriptions and administration of drugs

13. Tools for Optimizing Medication Safety (TOP-MEDS) - 2012 | Digital Healthcare Research
    digital.ahrq.gov/ahrq-funded-projects/tools-optimizing-medication-safety-top-meds/annual-summary/2012
    January 01, 2012 - initiative to conduct research and provide education to advance the optimal use of therapeutics such as drugs … High-risk commonly used drugs such as opioid analgesics are frequently selected and dosed improperly. … Drug name confusion causes patients to receive the wrong drugs. … Consumers use drugs unsafely because drug information is limited and confusing.

14. Improving Lab Follow-up by Delivering an Enhanced Medication List to Outpatient Physician Practices | Digital Healthcare Research
    digital.ahrq.gov/ahrq-funded-projects/improving-lab-follow-delivering-enhanced-medication-list-outpatient-physician
    January 01, 2022 - reminders specifically related to the patient on drug-drug interactions, drug-lab interactions, and drugs … support rules to medication history documents in selected areas, such as inadequate lab monitoring, drugs … with abnormal labs, or drugs to avoid in the elderly. … Physicians strongly agreed that medication histories helped discover drugs which were previously unknown

15. Assessment of Pediatric Look-Alike, Sound-Alike (LASA) Substitution Errors - 2010 | Digital Healthcare Research
    digital.ahrq.gov/ahrq-funded-projects/assessment-pediatric-look-alike-sound-alike-lasa-substitution-errors/annual-summary/2010
    January 01, 2010 - Beginning with 17,000 medications, the team eliminated LASA pairs where one of the drugs in the pair … is either IV, topical, or where the pairs represent similar drugs (e.g. extended-release versions of … These are the drugs that will be included in the Delphi process to identify pairs that are of greatest … they have identified a Food and Drug Administration file that contains cross-references for brand name drugs … with their corresponding generic names, allowing the electronic linkage of drugs that are the same but

16. Improving drug prescribing in a primary care practice | AHRQ Digital Healthcare Research: Informing Improvement in Care Quality, Safety, and Efficiency
    digital.ahrq.gov/health-it-tools-and-resources/health-it-costs-and-benefits-database/improving-drug-prescribing
    March 01, 1984 - Purpose of Study:  Increase use of generic drugs Years of study:  1979-1981 Study Design:  RCT Outcomes … Intervention:  Physicians were randomized to receive either a computer-generated notification for 28 common drugs … Clinical Outcomes:  Generic prescribing outcomes: The authors report that the rate of use of generic drugs

17. Assessment of Pediatric Look-Alike, Sound-Alike Substitution Errors (pdf file)
    digital.ahrq.gov/sites/default/files/docs/activity/r03hs018841-basco-annual-summary-2012.pdf
    January 01, 2012 - The Delphi process identified the drugs that the participants thought to be of high potential patient … team used a Food and Drug Administration (FDA) file that cross-referenced the brand name and generic drugs … drug pairs included in the final round of the Delphi process did not have a person who received both drugs … For 505 pairs (83 percent), the cumulative total of subjects who received both drugs in a pair was 3,610 … project team identified 20 LASA pairs (3 percent) where greater than 1,000 subjects received both drugs

18. Assessment of Pediatric Look-Alike, Sound-Alike Substitution Errors (pdf file)
    digital.ahrq.gov/sites/default/files/docs/activity/assessment_of_pediatric_look_alike__sound_alike__lasa__substitution_errors_2010pdf_2.pdf
    March 01, 2012 - Beginning with 17,000 medications, the team eliminated LASA pairs where one of the drugs in the pair … is either IV, topical, or where the pairs represent similar drugs (e.g. extended-release versions of … These are the drugs that will be included in the Delphi process to identify pairs that are of greatest … have identified a Food and Drug Administration file that contains cross-references for brand name drugs … with their corresponding generic names, allowing the electronic linkage of drugs that are the same

19. Computer-assisted medication review for asthmatic patients as a basis for intervention. Constructing and validating an algorithmic computer instrument in pharmacy practice | AHRQ Digital Healthcare Research: Informing Improvement in Care Quality, Safety, and Efficiency
    digital.ahrq.gov/health-it-tools-and-resources/health-it-costs-and-benefits-database/computer-assisted-medication
    October 01, 2004 -   Dutch asthma patients between ages 13 and 40 who received four or more prescriptions for pulmonary drugs … algorithmic computer instrument was constructed by manually identifying patients not using optimal levels of drugs … conducting searches of the InterAction pharmacy database using changing combinations and amounts of drugs

20. Evaluation of computer based clinical decision support system and risk chart for management of hypertension in primary care: randomised controlled trial | AHRQ Digital Healthcare Research: Informing Improvement in Care Quality, Safety, and Efficiency
    digital.ahrq.gov/health-it-tools-and-resources/health-it-costs-and-benefits-database/evaluation-computer-based-0
    March 11, 2000 - Method:  Measures of absolute cardiovascular risk, blood pressure, and prescriptions of cardiovascular drugs … The chart only group was twice as likely to be prescribed two classes of cardiovascular drugs and over … three times as likely to be prescribed three or more classes of drugs compared with the other groups